Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00212199 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Brief Counseling for Weight Management
A Phase 4 study of 1. Obesity, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 4
- Development phase
- 246
- Enrollment target
- 1
- Study location
NCT00212199 is a Phase 4 study of 1. Obesity that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 246 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00212199, a Phase 4 study of 1. Obesity, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 246 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effectiveness of three different methods for delivering weight management information. Two methods utilize an obesity drug and the third method utilizes brief behavioral counseling sessions only.
Conditions Studied
Interventions
- DRUG orlistat
- BEHAVIORAL Brief cognitive behavioral counseling
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2002-01 |
| Est. Completion | 2004-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00212199
The ClinicalTrials.gov registry entry for NCT00212199 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with 1. Obesity appearing as the primary indexed condition, and to 2 interventions - of which orlistat is the first listed.
NCT00212199 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00212199 about?
NCT00212199 is a clinical study titled "Effectiveness of Brief Counseling for Weight Management". The purpose of this study is to test the effectiveness of three different methods for delivering weight management information. Two methods utilize an obesity drug and the third method utilizes brief behavioral counseling sessions only.
What is the current status of trial NCT00212199?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 246 participants. The study started on 2002-01. Estimated completion is 2004-08.
What conditions does trial NCT00212199 study?
This clinical trial studies the following conditions: 1. Obesity.
What interventions are being tested in trial NCT00212199?
The interventions under investigation include: orlistat (DRUG), Brief cognitive behavioral counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00212199?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00212199 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.